Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

Recruiting

Back to Acute Myeloid Leukemia (AML) in Remission trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(17 sites)

Belgium

L'Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Brussels

Cliniques Universitaires Saint-Luc (CUSL), Brussels

Department of Pediatric Hematology, Oncology and SCT, Ghent University Hospital, Ghent

University Hospital Leuven, Leuven

Centre Hospitalier Régional de la Citadelle (CHR)/CHU Liège, Liège

Denmark

Paediatric Stem Cell Transplant and Immune Deficiency, Department of Pediatric and Adolescent Medicine, Section 4072, Rigshospitalet University Hospital of Copenhagen, Copenhagen

Finland

Division of Hematology, Oncology, and Stem Cell Transplantation, The New Children's Hospital, Helsinki University Hospital, Helsinki

Hong Kong

Department of Pediatrics and Adolescent Medicine, Hong King Children's Hospital, Hong Kong

Israel

Schneider Children's Medical Center of Israel, Petah Tikva

Lithuania

Vilnius University Hospital Santaros Klinikos Center for Pediatric Oncology and Hematology, Vilnius

Netherlands

Princess Máxima Center for Pediatric Oncology, Utrecht

Norway

Department of Pediatric Hematology and Oncology, Oslo University HospitalOslo University Hospital, Oslo

Spain

Stemcelltransplant unit Hospital Niño Jesús, Madrid

Sweden

Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg

Barncancercentrum, avdelning 64, Skane University Hospital, Lund

Pediatric Hematology immunology and stem cell transplantation Astrid Lindgren children's Hospital Huddinge K86-88, Stockholm

Childrens department for Blood and tumor diseases Uppsala University Hospital, Uppsala